X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
The outsourcing question... - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Nov 11, 2003

    The outsourcing question...

    In the last decade, India has emerged as one of the fastest growing economies in the world, growing at an average of about 6%. During this period, India has made a significant transition from being primarily an agrarian economy to an economy where manufacturing and services now play an important role in aiding the country's GDP growth. Further, India's success in outsourcing capabilities has already put the country on the global map. The software-outsourcing story is already in top of the league. Some other industries, which aim to follow a similar growth path, are pharma and auto ancillaries.

    In a poll conducted last week on Equitymaster, we tried to find out as to what do our readers think about - Which sector will benefit the most from the growing outsourcing trend? The options given to them were auto ancillaries, pharma and software. The results of the same are depicted in the chart above. Not much to our surprise, the software sector (51%) continues to dominate investor expectations of growth and benefits from the outsourcing trend. Pharma outsourcing was second with a distant 26% followed closely by auto ancillaries (23%).

    The outsourcing story has been in the limelight ever since major world economies started witnessing a slowdown. With global companies finding it difficult to grow, they increasingly looked at destinations that could help them to reduce their costs, for both manufacturing as well as services sectors. India was an ideal destination for outsourcing as it offered quality services at reasonably low costs. Indian companies even now are able to offer their expertise at relatively lesser costs than their international counterparts. While the biggest outsourcing story so far has been in the software sector, auto ancillaries and Pharma are also likely to be a thriving outsourcing hub for major global companies and economies.

    Auto ancillary companies in the country have already proven their mettle in the international markets. This is evident from the robust increase in exports, which were close to US$ 800 m worth (a jump of 40% over last year) of auto components from the country in FY03. Further with major global auto majors of the likes of Ford and GM increasingly looking at India for outsourcing auto components in an attempt to reduce costs, the story is far from over.

    On the pharma outsourcing front, we feel that the potential of Indian pharma companies to produce low cost quality-competitive pharma products in large quantities augur well for the domestic industry. Further, with India having USFDA approved manufacturing plants, India would be an ideal outsourcing destination. Indian companies have also proved their mettle in the pharma research field and due to this we may witness high-end research work also coming to the Indian shores. Already we have witnessed an early indicator of the same. Domestic pharma major, Ranbaxy and US major GSK Consumer have already entered into a drug discovery and clinical development collaboration.

    However, all said and done, up till now, the biggest outsourcing story for India has been in the software sector. While, off late, there have been campaigns against outsourcing in certain US states, because of job losses in government departments due to outsourcing of jobs to India, this is not likely to spread to the private sector companies. In fact, the economical sense that outsourcing makes would prevent this backlash from spreading too far. At the same time, the fact is that while the pressure on billing rates is likely to continue, Indian software companies are trying hard to grow on the volumes front. To gain acceptance in the global market, you need size and Indian companies are well on course to achieving the same.

    In conclusion, while all of the above sectors seem well poised to grow, we feel that the software and the pharma industries are best placed at the moment to reap the benefits of the growing outsourcing opportunities because size does matter and both these industries are relatively larger than the auto ancillary industry. Further, amongst the two mentioned above, the software sector has already shown rapid growth over the last couple of years and hence, while the growth will definitely continue, it will be at a relatively slower pace.

    At the same time, for the pharma and auto ancillary sectors, the outsourcing story has just begun and we may witness strong growth rates in business over the coming years. However readers must realise that not all companies in these sectors will benefit in the same way. So to sum it up, we feel that one can zero-in on 'select' stories across the three sectors, which are yet to unfold. However as we continue to stress, the selection should be based on solid fundamental factors.

     

     

    Equitymaster requests your view! Post a comment on "The outsourcing question...". Click here!

      
     

    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Why NOW Is the WORST Time for Index Investing (The 5 Minute Wrapup)

    Aug 18, 2017

    Buying the index now will hardly help make money in stocks even in ten years.

    Trump Takes a Beating (Vivek Kaul's Diary)

    Aug 18, 2017

    Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.

    How To Read Your Mutual Fund Account Statement Correctly (Outside View)

    Aug 17, 2017

    PersonalFN simplifies the mutual fund account statement for you.

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process) (The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE SENSEX


    Aug 18, 2017 (Close)

    MARKET STATS